Oncology News Today

08/12/2025

📰 NEWS: New prehabilitation guidelines will help improve outcomes for people with cancer and shorten hospital stays

Research suggests that prehabilitation can provide a number of benefits, such as reducing some of the complications caused by cancer treatment and speeding up people’s recovery as well as enhancing their quality of life. This can all lead to shorter hospital stays and cost savings for the healthcare system.

Read more: https://oncologynewstoday.co.uk/new-prehabilitation-guidelines-will-help-improve-outcomes-for-people-with-cancer-and-shorten-hospital-stays/

Pictured: June Davis, Lead Nursing and Allied Health Professional Advisor at Macmillan Cancer Support and co-chair of the guidelines

World Cancer Research Fund National Institute for Health and Care Research

A new set of guidelines has been launched to help ensure better prehabilitation services for people living with cancer.

05/12/2025

📰 NEWS: Home prostate cancer screening trial means faster results

Testing for prostate cancer with a few drops of blood and a mobile phone could mean faster diagnosis thanks to a new ground-breaking trial.

Quicker screening for prostate cancer, which is diagnosed in 50,000 men every year, may soon become a reality.

The innovative approach, thought to be the first of its kind in the world for prostate cancer screening, allows patients to test themselves from the comfort of their home. After receiving a lateral flow test through the post, they take a simple finger-prick blood sample to screen for prostate cancer.

🔗 Read more here: https://oncologynewstoday.co.uk/home-prostate-cancer-screening-trial-means-faster-results/

Mid and South Ess*x NHS Foundation Trust

04/12/2025

📰 Barking, Havering and Redbridge University Hospitals NHS Trust has launched a new thoracoscopy service to help diagnose lung cancer quicker.

🔗 Read more here:

Barking, Havering and Redbridge University Hospitals NHS Trust has launched a new thoracoscopy service to help diagnose lung cancer quicker.

03/12/2025

📰A new national research study, led by researchers at The Clatterbridge Cancer Centre NHS Foundation Trust in Liverpool and University Hospitals Birmingham NHS Foundation Trust, has opened to investigate whether magnetic resonance imaging (MRI) screening should become standard practice for detecting breast cancer that has spread to the brain.

🔗 Read more here:

A new national research study, led by researchers at The Clatterbridge Cancer Centre NHS Foundation Trust in Liverpool and University Hospitals Birmingham, has opened to investigate whether magnetic resonance imaging (MRI) screening should become standard practice for detecting breast cancer that ha...

02/12/2025

📰Academics from the University of Leicester have found that the risk of developing cancer following a prediabetes diagnosis is greater in those aged between 55 and 75 years than any other age group.

Previous research has indicated that elevated blood glucose levels are associated with an increased risk of developing cancer.

🔗 Read more here:

Academics from the University of Leicester have found that the risk of developing cancer following a prediabetes diagnosis is greater in those aged between 55 and 75 years than any other age group.

01/12/2025

📰 Five smart technologies that act as a “second pair of eyes” during bowel examinations have been conditionally recommended by National Institute for Health and Care Excellence for NHS use, potentially helping doctors spot harmful growths that could turn into cancer

🔗 Read more here:

Five smart technologies that act as a "second pair of eyes" during bowel examinations have been conditionally recommended by NICE for NHS use, potentially helping doctors spot harmful growths that could turn into cancer.

28/11/2025

📰 University Hospitals of North Midlands NHS Trust patients needing treatment for urological cancers, kidney stones, urinary infections or prostate problems are set to benefit from a newly relocated unit that makes specialist care quicker and easier.

🔗 Read more here:

Patients at University Hospitals of North Midlands NHS Trust needing treatment for urological cancers, kidney stones, urinary infections or prostate problems are set to benefit from a newly relocated unit that makes specialist care quicker and easier.

27/11/2025

📰 A new international research group has been created to advance the use of biomaterials for bone regeneration and bone cancer.

Pictured: Dr Lucas Souza at the Royal Orthopaedic Hospital. Credit: Edward Moss Photography.

The Royal Orthopaedic Hospital, Birmingham
Aston University

🔗 Read more here:

Biomedical Technologies for Regenerative Orthopaedics (BioTROCS) is a new joint research group that brings together the Royal Orthopaedic Hospital, Aston University and the Brazilian Aeronautics Institute of Technology (ITA).

25/11/2025

📰 The first men have been invited to join the ambitious £42 million TRANSFORM screening trial, kicking off the biggest prostate cancer screening study in a generation.

The trial will test the most promising prostate cancer screening techniques available – including a saliva test to assess genetic risk of the disease – to identify the safest, most accurate and most cost-effective way to screen men.

The TRANSFORM screening trial is co-led by six of the world’s leading prostate cancer researchers – including Professor Ros Eeles from The Institute of Cancer Research, London.

The trial will be delivered in partnership with the NHS through the National Institute for Health and Care Research (NIHR), which has committed £16m, with the remaining £26m funded
by Prostate Cancer UK.

🔗 Read more here:

The first men have been invited to join the ambitious £42 million TRANSFORM screening trial, kicking off the biggest prostate cancer screening study in a generation.

24/11/2025

📰 New research has ruled out hormone signalling as the reason why men with acute myeloid leukaemia (AML) tend to have poorer outcomes than women, even when treated with the same intensive chemotherapy – a finding that helps refine future research and could influence clinical trial design.

The study, led by researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust found that although AML cells express high levels of androgen receptors – proteins that respond to male s*x hormones like testosterone – they do not appear to influence how the cancer grows or responds to treatment.

The findings suggest that hormone signalling is not responsible for the s*x-based survival gap in AML, and that other biological factors are likely at play.

🔗 Read more here:

New research has ruled out hormone signalling as the reason why men with acute myeloid leukaemia tend to have poorer outcomes than women, even when treated with the same intensive chemotherapy – a finding that helps refine future research and could influence clinical trial design.

21/11/2025

📰 Amethyst Healthcare has announced the creation of Europe’s largest independent cancer care platform following its combination with Stingray Healthcare, a leading European oncology network headquartered in Lausanne, Switzerland

🔗 Read more here:

Amethyst Healthcare has announced the creation of Europe’s largest independent cancer care platform following its combination with Stingray Healthcare, a leading European oncology network headquartered in Lausanne, Switzerland.

20/11/2025

📰 NEWS: A University of Brighton study has looked at why patients experience debilitating fatigue after breast cancer treatment and how the brain could aid recovery.

🔗Read more here:

A University of Brighton study has looked at why patients experience debilitating fatigue after breast cancer treatment and how the brain could aid recovery.